Jose, S;
Quinn, K;
Hill, T;
Leen, C;
Walsh, J;
Hay, P;
Fisher, M;
... Fidler, S; + view all
(2014)
Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy.
AIDS
, 28
(9)
pp. 1333-1339.
10.1097/QAD.0000000000000242.
![[thumbnail of Laboratory_adverse_events_and_discontinuation_of.11.pdf]](https://discovery.ucl.ac.uk/style/images/fileicons/application_pdf.png) Preview |
PDF
Laboratory_adverse_events_and_discontinuation_of.11.pdf Download (335kB) |
Abstract
Few data describe antiretroviral treatment (ART)-related adverse events when treatment is initiated at CD4 cell counts more than 350 cells/μl. We compared rates of laboratory-defined adverse events (LDAEs) according to CD4 cell count at initiation.
| Type: | Article |
|---|---|
| Title: | Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy. |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1097/QAD.0000000000000242 |
| Publisher version: | http://dx.doi.org/10.1097/QAD.0000000000000242 |
| Additional information: | © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health > Infection and Population Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1422648 |
Archive Staff Only
 |
View Item |
